Clinical efficacy of prevention against infectious complication after transrectal prostate biopsy and molecular and microbiological analysis of rectal Escherichia coli with quinolone-resistance

Clinical efficacy of prevention against infectious complication after transrectal prostate biopsy and molecular and microbiological analysis of rectal Escherichia coli with quinolone-resistance - Clinical efficacy of prevention against infectious complication after transrectal prostate biopsy

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000009755

Enrollment

1000

Registered

2013-01-11

Start date

2013-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

suspected prostate cancer

Interventions

quinolone-resistant E coli or not

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: suspected prostate cancer

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
prevention of acute bacterial prostatitis	—

Countries

Japan

Contacts

Public ContactSatoshi Takahashi

Sapporo Medical University School of Medicine, Department of Urology

stakahas@sapmed.ac.jp011-611-2111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026